Home » Stocks » ICU Medical

ICU Medical, Inc. (ICUI)

Stock Price: $178.88 USD 1.18 (0.66%)
Updated Aug 10, 2020 4:00 PM EDT - Market closed
After-hours: $186.00 +7.12 (3.98%) Aug 10, 4:35 PM

Stock Price Chart

Key Info

Market Cap 3.73B
Revenue (ttm) 1.26B
Net Income (ttm) 86.87M
Shares Out 20.83M
EPS (ttm) 4.03
PE Ratio 44.39
Forward PE 28.65
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 10, 2020
Last Price $178.88
Previous Close $177.70
Change ($) 1.18
Change (%) 0.66%
Day's Open 179.60
Day's Range 177.72 - 181.82
Day's Volume 185,244
52-Week Range 148.89 - 236.51

More Stats

Market Cap 3.73B
Enterprise Value 3.44B
Earnings Date (est) Aug 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 20.83M
Float 19.37M
EPS (basic) 4.21
EPS (diluted) 4.03
FCF / Share 2.88
Dividend n/a
Dividend Yield n/a
Earnings Yield 2.25%
FCF Yield 1.60%
Payout Ratio n/a
Shares Short 308,257
Short Ratio 1.65
Short % of Float 1.94%
Beta 0.51
PE Ratio 44.39
Forward PE 28.65
P/FCF Ratio 62.36
PS Ratio 2.95
PB Ratio 2.69
Revenue 1.26B
Operating Income 63.35M
Net Income 86.87M
Free Cash Flow 59.75M
Net Cash 289.67M
Net Cash / Share 13.90
Gross Margin 38.62%
Operating Margin 5.01%
Profit Margin 6.90%
FCF Margin 4.73%
ROA 5.51%
ROE 6.53%
ROIC 11.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 2
Overweight 1
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$222.33*
(24.29% upside)
Low
199
Current: $178.88
High
240
Target: 222.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue1,2661,4001,293379342309314317302283
Revenue Growth-9.56%8.31%240.72%11.04%10.48%-1.42%-1%4.86%6.8%-
Gross Profit472570426201181151155157142129
Operating Income59.9650.16-5.2982.9468.5739.0451.9561.2865.2247.66
Net Income10128.7968.6463.0844.9926.3440.4241.2844.6729.92
Shares Outstanding20.6320.3919.6116.1715.8515.2814.6914.2213.8413.61
Earnings Per Share4.691.333.293.662.731.682.652.803.152.16
EPS Growth252.63%-59.57%-10.11%34.07%62.5%-36.6%-5.36%-11.11%45.83%-
Operating Cash Flow10216015489.9464.2066.3465.7366.2764.4933.10
Capital Expenditures-106-100-79.68-24.55-10.34-17.59-19.45-20.300.38-22.28
Free Cash Flow-4.0960.2074.7465.3953.8548.7546.2845.9864.8610.82
Cash & Equivalents29338230044537734729722616093.36
Net Cash / Debt29338230044537734729722616093.36
Assets1,6921,5851,497705627541500429361310
Liabilities31532229944.5346.9532.8534.9237.6640.5437.94
Book Value1,3771,2641,198660580508465391321272
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ICU Medical, Inc.
Country United States
Employees 8,000
CEO Vivek Jain

Stock Information

Ticker Symbol ICUI
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: ICUI
IPO Date March 31, 1992

Description

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms, as well as related professional services. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.